This episode is designed for listeners interested in clinical research, peptide science, endocrinology, and translational medicine, offering an evidence-based perspective without speculation or medical advice.

Topics include:

• Tesamorelin peptide mechanism of action
• Preclinical and animal studies
• Phase II and Phase III clinical trial data
• FDA approval and HIV-associated lipodystrophy
• Growth hormone, IGF-1, and metabolic effects
• Safety, limitations, and ongoing research